about
Expression of osteopontin in patients with thyroid dysfunctionOsteopontin undergoes polymerization in vivo and gains chemotactic activity for neutrophils mediated by integrin alpha9beta1.Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients.The RGD domain of human osteopontin promotes tumor growth and metastasis through activation of survival pathwaysElevated tumor and serum levels of the hypoxia-associated protein osteopontin are associated with prognosis for soft tissue sarcoma patients.Discovery of pathway biomarkers from coupled proteomics and systems biology methodsOsteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes.Microenvironment, oncoantigens, and antitumor vaccination: lessons learned from BALB-neuT mice.Far beyond the usual biomarkers in breast cancer: a review.Energy metabolism during anchorage-independence. Induction by osteopontin-c.Pre- and post-translational regulation of osteopontin in cancer.Functional heterogeneity of osteopontin isoforms in non-small cell lung cancer.Nuclear osteopontin-c is a prognostic breast cancer marker.Role of traditional and new biomarkers in breast carcinogenesis.Osteopontin splice variant as a potential marker for metastatic disease in pancreatic adenocarcinomaAssociations between the Genetic Polymorphisms of Osteopontin Promoter and Susceptibility to Cancer in Chinese Population: A Meta-Analysis.Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer.Osteopontin splice variants are differential predictors of breast cancer treatment responsesOsteopontin Fragments with Intact Thrombin-Sensitive Site Circulate in Cervical Cancer PatientsRole of osteoprotegerin and its gene polymorphisms in the occurrence of left ventricular hypertrophy in essential hypertensive patients.Osteopontin splice variants differentially exert clinicopathological features and biological functions in gastric cancerPrognostic Value of Osteopontin Splice Variant-c Expression in Breast Cancers: A Meta-Analysis.Transgenic mammary epithelial osteopontin (spp1) expression induces proliferation and alveologenesis.Osteopontin is associated with increased arterial stiffness in rheumatoid arthritis.Association of osteopontin and cyclooxygenase-2 expression with breast cancer subtypes and their use as potential biomarkersExpression of a prometastatic splice variant of osteopontin, OPNC, in human pancreatic ductal adenocarcinoma.Osteopontin induces beta-catenin signaling through activation of Akt in prostate cancer cells.Osteopontin-a splice variant is overexpressed in papillary thyroid carcinoma and modulates invasive behavior.Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancersEffect of a 12-month exercise intervention on serum biomarkers of angiogenesis in postmenopausal women: a randomized controlled trial.Osteopontin splice variants expressed by breast tumors regulate monocyte activation via MCP-1 and TGF-β1.Intracellular osteopontin (iOPN) and immunity.Osteopontin: a potentially important therapeutic target in cancer.Role of osteopontin in the pathophysiology of cancer.Osteopontin as a therapeutic target for cancer.Influence of osteopontin expression on the metastatic growth of CC531 rat colorectal carcinoma cells in rat liver.Glycosylation and liver cancer.Metabolism in cancer metastasis.Osteopontin splice variants expression is involved on docetaxel resistance in PC3 prostate cancer cells.Tumor-derived microparticles induce bone marrow-derived cell mobilization and tumor homing: a process regulated by osteopontin.
P2860
Q28486293-1EC3BBC4-60A1-449D-9B6D-AF340E892DFBQ28509843-A331452B-F9BB-48C3-A753-1E0FB062BA1EQ30318127-568E77E8-383F-4677-94B0-BBC69B798330Q33540190-676B5577-9455-4E08-BC7F-3B0BA9477C58Q33551004-392CD383-58C9-4079-975D-B63333DE0E81Q33737009-488F3F2B-65B1-44AC-A16D-CBAC3DB86C22Q33766277-99B7C791-B05E-49A0-91A4-34A875B8031EQ33786788-913ED205-8B9A-4591-9A64-D6C3F6FB453BQ33935217-5335797F-0851-408C-BEE0-6CF675795402Q34089808-F36E702C-27F7-4A61-91E4-5A0A6F317FFCQ34939938-EA31955F-5DB0-4C3A-9907-1AE3BEE740FEQ35065341-873D18B5-E4F3-4529-B6E5-22AB10D397E9Q35098350-E92A1708-7D5D-4B3D-BE79-59696696B3E9Q35572905-AC588C3E-7D3D-42AC-992C-2D977E4E0411Q35735234-05F3C727-FFCF-44DC-8239-C2F60697F55AQ35744040-54C03E98-4842-4428-8F09-A313FDD7B7F3Q35840714-0F36B102-A371-4316-B5D6-0435F555F1D2Q36072882-265F4BAB-FE8D-4626-9572-6FAA9C454BFCQ36095801-1ED16302-A621-492D-9479-8A5AB8A04E3BQ36151776-BE5102C6-A907-42C7-AE36-24BBDFC08AC8Q36503987-EACADDDA-96C0-4E2A-B0CA-69EA31B7AA33Q37100582-32731EFA-ABDA-401D-A5A7-1560BDCECD3EQ37194860-AFDB99AB-11D6-4F11-A2CC-521C6D69D09BQ37260891-071E998B-E463-44B9-BA20-991C152A44D7Q37326197-B35D5D71-F08D-4B49-84AC-6BF347DC8A64Q37421879-D4EB8F1E-4242-4E47-A1A5-E3B03335E18FQ37455849-45AA8A6E-3E57-4C59-8F7B-0287A3991F86Q37588399-BA71C66A-A11E-43FF-8FA8-FB3443F11990Q37625382-00772093-EC57-49BB-8667-BB609C8BB3F9Q37686655-C42DDCA7-A2EA-45D4-8480-31703E06F921Q37729373-CCD5FDA4-0B24-451E-8DC5-76693079C505Q37817038-193213B8-6B27-4EAA-8105-3354ED2DD05EQ37896087-401CA4F1-E240-4242-8500-1F59C0A0AFBBQ38198463-2A9B7154-F4FF-4188-AA20-ACAC05D11868Q38217758-B729D173-6A7B-4BD0-BC56-39DC95D6D267Q38332539-3477B77C-1A6E-4A45-9938-838510BD8EFFQ38366329-970F984C-76C4-435D-9190-A1C5A5F52872Q38583999-95382B76-147F-4875-9AA4-F95E0B352D23Q38832738-179813BA-472D-46E6-9569-32F68A9E6236Q39042430-0F5B8BD9-586A-4E68-A6B5-584ECB45716F
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Osteopontin-c is a selective marker of breast cancer
@ast
Osteopontin-c is a selective marker of breast cancer
@en
Osteopontin-c is a selective marker of breast cancer
@nl
type
label
Osteopontin-c is a selective marker of breast cancer
@ast
Osteopontin-c is a selective marker of breast cancer
@en
Osteopontin-c is a selective marker of breast cancer
@nl
prefLabel
Osteopontin-c is a selective marker of breast cancer
@ast
Osteopontin-c is a selective marker of breast cancer
@en
Osteopontin-c is a selective marker of breast cancer
@nl
P2093
P3181
P356
P1476
Osteopontin-c is a selective marker of breast cancer
@en
P2093
Elizabeth Shaughnessy
Gary A Pestano
Georg F Weber
John K Hurley
Kristie A Vanpatten
Mana Mirza
P304
P3181
P356
10.1002/IJC.23204
P407
P577
2008-02-15T00:00:00Z